{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:12:20Z","timestamp":1771852340546,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T00:00:00Z","timestamp":1103846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s00213-004-2117-y","type":"journal-article","created":{"date-parts":[[2004,12,23]],"date-time":"2004-12-23T16:30:22Z","timestamp":1103819422000},"page":"838-845","source":"Crossref","is-referenced-by-count":10,"title":["Differential effects of topiramate in patients with traumatic brain injury and obesity\u2014a case series"],"prefix":"10.1007","volume":"179","author":[{"given":"Ornah T.","family":"Dolberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaby","family":"Barkai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yigal","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaul","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,12,24]]},"reference":[{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/070674370204700309","volume":"47","author":"JC Appolinario","year":"2002","unstructured":"Appolinario JC, Fontenelle LF, Papelbaum M, Bueno JR, Coutinho W (2002) Topiramate use in obese patients with binge eating disorder: an open study. Can J Psychiatry 47:271\u2013273","journal-title":"Can J Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10401230309085669","volume":"15","author":"J Birt","year":"2003","unstructured":"Birt, J (2003) Management of weight gain associated with antipsychotics. Ann Clin Psychiatry 15:49\u201358","journal-title":"Ann Clin Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/oby.2003.102","volume":"11","author":"GA Bray","year":"2003","unstructured":"Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH (2003) A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 11:722\u2013733","journal-title":"Obes Res"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00004714-200106000-00015","volume":"21","author":"JR Calabrese","year":"2001","unstructured":"Calabrese JR, Keck PE, McElroy SL, Shelton MD (2001) A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol 21:340\u2013342","journal-title":"J Clin Psychopharmacol"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-0327(01)00337-8","volume":"69","author":"LL Carpenter","year":"2002","unstructured":"Carpenter LL, Leon Z, Yasmin S, Price LH (2002) Do obese depressed patients respond to topiramate? A retrospective chart review. J Affect Disorder 69:251\u2013255","journal-title":"J Affect Disorder"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1034\/j.1399-5618.2001.30501.x","volume":"3","author":"KNR Chengappa","year":"2001","unstructured":"Chengappa KNR, Gershon S, Levine J (2001a) The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipolar Disord 3:215\u2013232","journal-title":"Bipolar Disord"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0924-9338(01)00562-4","volume":"16","author":"KNR Chengappa","year":"2001","unstructured":"Chengappa KNR, Levine J, Rathore D, Parepally H, Atzert R (2001b) Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. Eur Psychiatry 16:186\u2013190","journal-title":"Eur Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4088\/JCP.v62n0612c","volume":"62","author":"F Colom","year":"2001","unstructured":"Colom F, Vieta E, Benabarre A, Reinares M, Corbella B, Gasto C (2001) Topiramate abuse in a bipolar patient with an eating disorder. J Clin Psychiatry 62:475\u2013476","journal-title":"J Clin Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR9","first-page":"198","volume":"45","author":"SM Dursun","year":"2000","unstructured":"Dursun SM, Devarajan S (2000) Clozapine weight gain, plus topiramate weight loss. Can J Psychiatry 45:198","journal-title":"Can J Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/070674370104600316","volume":"46","author":"SM Dursun","year":"2001","unstructured":"Dursun, SM, Devarajan S (2001) Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanism of action? Can J Psychiatry 46:50\u201351","journal-title":"Can J Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000054854","volume":"42","author":"A Erfurth","year":"2000","unstructured":"Erfurth A, Kuhn G (2000) Topiramate monotherapy in the maintenance treatment of bipolar I disorder: effects on mood, weight and serum lipids. Neuropsychobiology 42:50\u201351","journal-title":"Neuropsychobiology"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/ajp.156.6.968a","volume":"156","author":"A Gordon","year":"1999","unstructured":"Gordon A, Price LH (1999) Mood stabilization and weight loss with topiramate. Am J Psychiatry 156:968\u2013969","journal-title":"Am J Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR13","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/00004583-200112000-00003","volume":"40","author":"MC Lessig","year":"2001","unstructured":"Lessig MC, Shapira NA, Murphy TK (2001) Topiramate for reversing atypical antipsychotic weight gain. J Am Acad Child Adolesc Psych 40:1364","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.160.2.255","volume":"160","author":"SL McElroy","year":"2003","unstructured":"McElroy, SL, Arnold LM, Shapira NA (2003) Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 160:255\u2013261","journal-title":"Am J Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/j.1550-8528.1998.tb00690.x","volume":"6","author":"National Heart, Lung and Blood Institute (NHLBI) Obesity Task Force","year":"1998","unstructured":"National Heart, Lung and Blood Institute (NHLBI) Obesity Task Force (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6:51\u2013209","journal-title":"Obes Res"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4088\/JCP.v61n0508","volume":"61","author":"NA Shapira","year":"2000","unstructured":"Shapira NA, Goldsmith TD, McElroy SL (2000) Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 61:368\u2013372","journal-title":"J Clin Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4088\/JCP.v63n1104","volume":"63","author":"M Ameringen Van","year":"2002","unstructured":"Van Ameringen M, Mancini C, Pipe B, Campbell M, Oakman J (2002) Topiramate treatment for SSRI-induced weight gain in anxiety disorders. J Clin Psychiatry 63:981\u2013984","journal-title":"J Clin Psychiatry"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0387-7604(01)00230-3","volume":"23","author":"SJ Wallace","year":"2001","unstructured":"Wallace SJ (2001) Newer antiepileptic drugs: advantages and disadvantages. Brain Dev 23:277\u2013283","journal-title":"Brain Dev"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","volume":"66","author":"PJ Weiden","year":"2003","unstructured":"Weiden PJ, MacKell JA, McDonnell DD (2003) Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 66:51\u201357","journal-title":"Schizophr Res"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004850-200207000-00001","volume":"17","author":"U Werneke","year":"2002","unstructured":"Werneke U, Taylor D, Sanders TAB (2002) Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol 17:145\u2013160","journal-title":"Int Clin Psychopharmacol"},{"key":"PEIWorkflow-213-179-4_2005-05-10_13-44-38_CR21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1468-2982.2002.00380.x","volume":"22","author":"WB Young","year":"2002","unstructured":"Young WB, Hopkins MM, Shechter AL, Silberstein SD (2002) Topiramate: a case series in migraine prophylaxis. Cephalalgia 22:659\u2013663","journal-title":"Cephalalgia"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-2117-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2117-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:01:25Z","timestamp":1558641685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-2117-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,24]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-2117-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,24]]}}}